Clinical Trial Update: EvoLution of Neoadjuvant TreatMent in 'Triple-negative' or 'HER-2-positive' Breast Cancer Diagnosed in the EaRly Phase

View source ↗

Summary

A clinical trial update on evolving neoadjuvant treatment strategies for early-stage triple-negative or HER2-positive breast cancer that is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Breast Cancer | Status: RECRUITING